Why prostate cancer continues to catch Nigerian men unprepared

Prostate cancer is not new. It is not rare. And, in many cases, it is not even immediately fatal. Yet in Nigeria, it continues to claim lives in ways that suggest not just a medical problem, but a deeper failure of awareness, behaviour, and health system response. The warning from Joshua Oluwayomi, a medical officer at the University of Medical Sciences Teaching Hospital in Ondo State, is blunt: prostate cancer is evolving into a silent crisis—not because it is untreatable, but because it is detected too late.

At the centre of this crisis is a paradox. Prostate cancer is one of the more manageable cancers when caught early, yet outcomes in Nigeria often reflect late-stage presentation. The gap between possibility and reality is not driven solely by biology, but by awareness and action—or the lack of both. Medically, prostate cancer begins in a small gland responsible for producing seminal fluid. Its progression is influenced by multiple risk factors, with age standing out as the most significant. The risk rises sharply after 50 and becomes more pronounced in men over 65. Genetics also plays a critical role; a family history—particularly involving a father or brother—significantly increases susceptibility.

But beyond these universal risk factors lies a more uncomfortable truth: prostate cancer disproportionately affects black men, both in incidence and aggressiveness. For a country like Nigeria, this is not a peripheral concern—it is central to the national health profile.

Yet awareness remains strikingly low. Unlike diseases that present with sudden or dramatic symptoms, prostate cancer often develops quietly. Early stages may produce no noticeable signs, allowing the disease to advance undetected. When symptoms do appear—difficulty urinating, weak urine flow, or blood in urine—they are frequently dismissed or attributed to less serious conditions. This tendency to normalise symptoms reflects a broader cultural pattern in men’s health: delayed engagement with care. Many men seek medical attention only when symptoms begin to interfere significantly with daily life. By that point, the window for simple, curative treatment may have narrowed. Oluwayomi emphasises that early-stage prostate cancer is often highly treatable. Interventions such as surgery or radiotherapy can offer strong outcomes when the disease is localised. Even in more advanced stages, modern treatments—ranging from hormone therapy to chemotherapy and targeted approaches—can control the disease and extend life.

Read Also: Four Nigerian startups selected for 10th Google Accelerator Africa cohort

In fact, the statistics are revealing. About one in eight men will develop prostate cancer in their lifetime, yet only around one in 40 to 45 die from it. This suggests that many men live long, manageable lives after diagnosis—provided the disease is detected in time. The problem, therefore, is not inevitability. It is timing.

Screening remains the most effective tool for early detection, but uptake in Nigeria is persistently low. Tests such as the Prostate-Specific Antigen (PSA) blood test and the Digital Rectal Examination are widely available and relatively straightforward. Yet they are underutilised, often due to a combination of limited awareness, stigma, fear, and misconceptions. For many men, screening is still perceived as unnecessary unless symptoms are present. Others avoid it due to discomfort with the procedures or anxiety about potential results. These behavioural barriers are compounded by systemic challenges, including limited access to routine preventive care and competing financial priorities.

The result is a pattern that health experts recognise all too well: late presentation, more complex treatment, and poorer outcomes. Lifestyle factors further complicate the picture. Diets high in red meat and fatty foods, combined with low intake of fruits and vegetables, may increase risk. Obesity and physical inactivity add another layer of vulnerability, reflecting broader shifts in lifestyle across urban and semi-urban Nigeria.

Hormonal influences also play a role. The prostate is regulated by male hormones, particularly testosterone, and prolonged exposure over time may contribute to abnormal cell growth. While these biological processes cannot be entirely controlled, their interaction with lifestyle choices underscores the importance of prevention. Still, prevention in prostate cancer is not absolute. As Oluwayomi points out, the disease cannot be completely avoided. But risk can be reduced, and outcomes can be significantly improved through early detection and timely intervention.